查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1252685

AI型臨床試驗解決方案供應商的全球市場和COVID-19影響分析:不同階段，各用途，各終端用戶，各國，各地區 - 產業分析，市場規模，市場佔有率，預測(2023年～2030年)

AI-based Clinical Trials Solution Provider Market with COVID-19 Impact Analysis, By Phase, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 285 Pages | 商品交期: 2-3個工作天內

價格

全球AI型臨床試驗解決方案供應商的市場規模在2022年估算為17億980萬美金，在2023年～2030年間預計將以年複合成長率23.9％的速度成長。

本報告提供全球AI型臨床試驗解決方案供應商市場相關調查分析，提供市場趨勢，各市場區隔·各地區的分析，企業簡介等資訊。

目錄

第1章 AI型臨床試驗解決方案供應商市場概要

第2章 摘要整理

  • 市場明細
    • 不同階段
    • 各用途
    • 各終端用戶
    • 各國
    • 各地區
  • 競爭考察

第3章 AI型臨床試驗解決方案供應商的主要的市場趨勢

  • 推動市場要素
    • 推動市場要素的影響分析
  • 阻礙市場要素
    • 阻礙市場要素的影響分析
  • 市場機會
  • 市場未來趨勢

第4章 AI型臨床試驗解決方案供應商產業的調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法律規範分析

第5章 AI型臨床試驗解決方案供應商市場:COVID-19影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析

第6章 AI型臨床試驗解決方案供應商市場情勢

  • 市場佔有率分析(2022年)
  • 明細資料:各主要製造商
    • 現有企業的分析
    • 新興企業的分析

第7章 AI型臨床試驗解決方案供應商市場:不同階段

  • 概要

第8章 AI型臨床試驗解決方案供應商市場:各用途

  • 概要

第9章 AI型臨床試驗解決方案供應商市場:各終端用戶

  • 概要

第10章 AI型臨床試驗解決方案供應商市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第11章 主要供應商分析

  • 競爭儀表板
  • 企業簡介
    • Antidote Technologies, Inc.
    • Saama Technologies
    • Unlearn.AI, Inc.
    • Phesi
    • Innoplexus
    • Deep 6 AI
    • Mendel.ai
    • Median Technologies
    • Intelligencia
    • Symphony AI
    • BioAge Labs, Inc.
    • AiCure, LLC
    • CONSILX
    • DEEP LENS AI
    • Halo Health Systems
    • Pharmaseal

第12章 分析師的全方位展望

第13章 附錄

Product Code: ANV1182

REPORT HIGHLIGHT

AI-based Clinical Trials Solution Provider Market size was valued at USD 1,709.8 million in 2022, expanding at a CAGR of 23.9% from 2023 to 2030.

Artificial intelligence can be used to diagnose disease, deliver healthcare, and even create novel medications while enhancing clinical trials. AI is vastly more efficient and faster than any system that only relies on human action. Because we haven't yet developed AI to the point where it can function completely autonomously, this will likely be the greatest issue going forward.

AI-based Clinical Trials Solution Provider Market- Market Dynamics:

The market for AI-based clinical trial solution providers is being driven by the growing adoption of AI-based platforms to enhance the productivity and efficacy of trials at different stages. Some of the other factors boosting the market development include the supportive efforts by the public and private sectors for various therapeutic areas. Additionally, the market is being supported by the growing knowledge of AI's applications in clinical trials, such as drug trial design, better patient selection, site selection, patient monitoring and others.

Since developing new drugs is an expensive and time-consuming procedure, using AI in drug trials may help reduce costs, improve clinical outcomes, and shorten trial times. For instance, Recursion Pharma and Takeda collaborated on research for rare illnesses in January 2020, and in less than 18 months, they evaluated preclinical and clinical molecules in over 60 different indications. AI can also be used to lessen prejudice in medical data, in addition. For instance, Genentech and Stanford University worked together to develop an open-source AI system to combat bias in drug studies. Additionally, major pharmaceutical firms are heavily implementing AI-based technologies in clinical settings due to the trend away from traditional practices and toward technology-based approaches.

AI-based Clinical Trials Solution Provider Market- Segmentation Analysis:

Based on the phase, the phase-II segment is expected to dominate the market during the forecast period due to the existence of numerous registered clinical studies that are currently in the second phase. In addition, the segment is growing as a result of the growing use of AI-based tools for data collection and analysis of immediate results of the overall intended outcome through drug trials in this stage. Additionally, the segment has a higher income share because this stage allows for the development, choice, and validation of measures related to the AI-based tool.

Based on the application, the oncology segment is expected to capture the major market share during the forecast period. The uptake of AI-enabled technologies is being influenced by the high incidence of cancer worldwide and a large number of oncology-related drug trials. Additionally, many players are creating and implementing oncology-based AI tools for clinical trials, which is accelerating the segment's development. For instance, Hematology-Oncology Associates of Central New York and Deep Lens teamed up in January 2022 to expand a drug trial program. The VIPER provided by Deep Lens will be used to pre-screen all patients to find those who are qualified for clinical trials.

AI-based Clinical Trials Solution Provider Market- Geographical Insights:

North America is expected to dominate the market during the forecast period. It is credited to the region's high number of AI-based start-ups. For instance, the American startup Bullfrog AI creates bfLEAP, a unique AI tool that enables precision medicine. Additionally, the adoption of AI-based technologies to improve the results of drug trials and increasing knowledge of these technologies are driving market expansion in the area. The region's demand for AI-based clinical trial solutions is being fueled in part by supportive government initiatives and an increase in key players' strategic initiatives.

AI-based Clinical Trials Solution Provider Market- Recent Development:

In March 2021, through Saama Technologies, Inc.'s Life Science Analytics Cloud, Datavant and Saama Technologies, Inc. created a collaborative agreement for mapping patient journeys across different real-world and clinical datasets (LSAC).

Key features of the study:

This proposed research study on the AI-based Clinical Trials Solution Provider market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the AI-based Clinical Trials Solution Provider market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the AI-based Clinical Trials Solution Provider market

The impact of COVID-19 on AI-based Clinical Trials Solution Provider market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the AI-based Clinical Trials Solution Provider market post-COVID will also be covered.

To give the users of this report a comprehensive view of the AI-based Clinical Trials Solution Provider market, we have also included a competitive landscape and key innovator analysis for the AI-based Clinical Trials Solution Provider market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the AI-based Clinical Trials Solution Provider market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global AI-based Clinical Trials Solution Provider market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET KEY PLAYERS:

Antidote Technologies, Inc.

Saama Technologies

Unlearn.AI, Inc.

Phesi

Innoplexus

Deep 6 AI

Mendel.ai

Median Technologies

Intelligencia

Symphony AI

BioAge Labs, Inc.

AiCure, LLC

CONSILX

DEEP LENS AI

Halo Health Systems

Pharmaseal

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY PHASE

Phase-I

Phase-II

Phase-III

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY APPLICATION:

Oncology

Cardiovascular Diseases

Neurological Diseases or Conditions

Metabolic Diseases

Infectious Diseases

Others

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY END-USER:

Pharmaceutical Companies

Academia

Others

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY REGION:

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. AI-based Clinical Trials Solution Provider Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Clinical Trials Solution Provider Market Snippet by Phase
    • 2.1.2. AI-based Clinical Trials Solution Provider Market Snippet by Application
    • 2.1.3. AI-based Clinical Trials Solution Provider Market Snippet by End-User
    • 2.1.4. AI-based Clinical Trials Solution Provider Market Snippet by Country
    • 2.1.5. AI-based Clinical Trials Solution Provider Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Clinical Trials Solution Provider Key Market Trends

  • 3.1. AI-based Clinical Trials Solution Provider Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Clinical Trials Solution Provider Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Clinical Trials Solution Provider Market Opportunities
  • 3.4. AI-based Clinical Trials Solution Provider Market Future Trends

4. AI-based Clinical Trials Solution Provider Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Clinical Trials Solution Provider Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Clinical Trials Solution Provider Market Landscape

  • 6.1. AI-based Clinical Trials Solution Provider Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Clinical Trials Solution Provider Market - By Phase

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Phase, 2022 & 2030 (%)
    • 7.1.2. Phase-I
    • 7.1.3. Phase-II
    • 7.1.4. Phase-III

8. AI-based Clinical Trials Solution Provider Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Neurological Diseases or Conditions
    • 8.1.5. Metabolic Diseases
    • 8.1.6. Infectious Diseases
    • 8.1.7. Others

9. AI-based Clinical Trials Solution Provider Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Academia
    • 9.1.4. Others

10. AI-based Clinical Trials Solution Provider Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. AI-based Clinical Trials Solution Provider Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- AI-based Clinical Trials Solution Provider Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Antidote Technologies, Inc.
    • 11.2.2. Saama Technologies
    • 11.2.3. Unlearn.AI, Inc.
    • 11.2.4. Phesi
    • 11.2.5. Innoplexus
    • 11.2.6. Deep 6 AI
    • 11.2.7. Mendel.ai
    • 11.2.8. Median Technologies
    • 11.2.9. Intelligencia
    • 11.2.10. Symphony AI
    • 11.2.11. BioAge Labs, Inc.
    • 11.2.12. AiCure, LLC
    • 11.2.13. CONSILX
    • 11.2.14. DEEP LENS AI
    • 11.2.15. Halo Health Systems
    • 11.2.16. Pharmaseal

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE AI-based Clinical Trials Solution Provider Market: Phase Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Phase
  • TABLE Global AI-based Clinical Trials Solution Provider Market, by Phase 2018-2030 (USD Million)
  • TABLE AI-based Clinical Trials Solution Provider Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global AI-based Clinical Trials Solution Provider Market, by Application 2018-2030 (USD Million)
  • TABLE AI-based Clinical Trials Solution Provider Market: Regional snapshot (2022)
  • TABLE AI-based Clinical Trials Solution Provider Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global AI-based Clinical Trials Solution Provider Market, by End-User 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global AI-based Clinical Trials Solution Provider Market, by Region 2018-2030 (USD Million)
  • TABLE North America AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
  • TABLE North America AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
  • TABLE North America AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
  • TABLE North America AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
  • TABLE Europe AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
  • TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
  • TABLE Latin America AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
  • TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)